ArticleCancer science2024

Altered tumor signature and T-cell profile after chemotherapy reveal new therapeutic opportunities in high-grade serous ovarian carcinoma.

Huiram Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.